Gene therapy for X-linked immunodeficiencies.
Kinnon
C
C
Department of Immunology, Institute of Child Health, London, UK.
O'Reilly
M A
MA
Pelham
A
A
Malcolm
S
S
Porter
C D
CD
Parkar
M H
MH
Collins
M K
MK
Leveinsky
R J
RJ
D000361:Agammaglobulinemia / Q000235:genetics; D002478:Cells, Cultured; D002874:Chromosome Mapping; D004303:Dosage Compensation, Genetic; D004591:Electrophoresis, Polyacrylamide Gel; D005808:Genes, Recessive; D005813:Genes, Synthetic; D008040:Genetic Linkage; D005819:Genetic Markers; D015316:Genetic Therapy; D005822:Genetic Vectors; D006412:Hematopoietic Stem Cells / Q000382:microbiology; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D012150:Polymorphism, Restriction Fragment Length; D011296:Prenatal Diagnosis; D011401:Promoter Regions, Genetic; D015375:Receptors, Interleukin-2 / Q000096:biosynthesis / Q000235:genetics; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis; D012190:Retroviridae / Q000235:genetics; D014162:Transfection; D014960:X Chromosome
D005819:Genetic Markers; D015375:Receptors, Interleukin-2; D011993:Recombinant Fusion Proteins